X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (56431) 56431
Book Review (8909) 8909
Publication (3037) 3037
Conference Proceeding (686) 686
Newsletter (609) 609
Book Chapter (338) 338
Book / eBook (257) 257
Magazine Article (34) 34
Dissertation (28) 28
Newspaper Article (15) 15
Web Resource (10) 10
Presentation (6) 6
Data Set (3) 3
Government Document (3) 3
Journal / eJournal (3) 3
Reference (3) 3
Trade Publication Article (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (47453) 47453
humans (45808) 45808
radiotherapy (34969) 34969
female (31699) 31699
oncology (30701) 30701
middle aged (27796) 27796
male (25704) 25704
aged (24588) 24588
adult (21141) 21141
cancer (20446) 20446
surgery (17618) 17618
chemotherapy (14436) 14436
treatment outcome (14227) 14227
care and treatment (12067) 12067
retrospective studies (12052) 12052
combined modality therapy (10889) 10889
neoplasm staging (10844) 10844
radiology, nuclear medicine & medical imaging (10807) 10807
aged, 80 and over (10792) 10792
radiotherapy, adjuvant (10344) 10344
prognosis (10270) 10270
radiation-therapy (10081) 10081
radiation (9108) 9108
survival (8767) 8767
follow-up studies (8493) 8493
radiation therapy (8198) 8198
medicine & public health (8122) 8122
carcinoma (8042) 8042
hematology, oncology and palliative medicine (6695) 6695
disease-free survival (6668) 6668
analysis (6666) 6666
breast cancer (6616) 6616
radiotherapy dosage (6587) 6587
chemotherapy, adjuvant (6585) 6585
survival rate (6533) 6533
research (6372) 6372
therapy (6171) 6171
survival analysis (5721) 5721
tumors (5606) 5606
health aspects (5509) 5509
antineoplastic combined chemotherapy protocols - therapeutic use (5228) 5228
patients (5056) 5056
risk factors (5040) 5040
irradiation (4983) 4983
breast neoplasms - radiotherapy (4966) 4966
abridged index medicus (4705) 4705
adolescent (4525) 4525
metastasis (4337) 4337
radiology (4202) 4202
breast neoplasms - surgery (4014) 4014
management (3983) 3983
time factors (3787) 3787
prostate cancer (3691) 3691
breast neoplasms - pathology (3654) 3654
young adult (3516) 3516
prospective studies (3481) 3481
recurrence (3479) 3479
patient outcomes (3450) 3450
trial (3384) 3384
chemoradiotherapy (3325) 3325
randomized-trial (3261) 3261
lymphatic metastasis (3240) 3240
cancer therapies (3128) 3128
multivariate analysis (3019) 3019
neoplasm recurrence, local (2838) 2838
clinical neurology (2835) 2835
prostatic neoplasms - radiotherapy (2819) 2819
brachytherapy (2811) 2811
antineoplastic agents - therapeutic use (2796) 2796
cancer patients (2796) 2796
kaplan-meier estimate (2788) 2788
child (2757) 2757
oncology, experimental (2751) 2751
diagnosis (2746) 2746
radiology and nuclear medicine (2721) 2721
squamous-cell carcinoma (2712) 2712
toxicity (2651) 2651
neoadjuvant therapy (2628) 2628
mastectomy (2627) 2627
risk (2610) 2610
usage (2468) 2468
adenocarcinoma (2459) 2459
carcinoma, squamous cell - radiotherapy (2451) 2451
quality of life (2451) 2451
neoplasms (2412) 2412
postoperative radiotherapy (2402) 2402
otorhinolaryngology (2395) 2395
head (2368) 2368
adjuvant chemotherapy (2343) 2343
neoplasm recurrence, local - pathology (2341) 2341
medicine (2329) 2329
carcinoma, squamous cell - pathology (2293) 2293
proportional hazards models (2249) 2249
magnetic resonance imaging (2240) 2240
women (2205) 2205
nuclear radiation (2182) 2182
animals (2130) 2130
adjuvant treatment (2086) 2086
clinical trials (2065) 2065
medical research (2064) 2064
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (160) 160
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (21) 21
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
UTL at Downsview - May be requested (4) 4
Lakeridge Health Sciences - Oshawa (3) 3
Online Resources - Online (2) 2
Physics - Stacks (2) 2
St. Michael's Hospital - Stacks (2) 2
Gerstein Science - Missing (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
Scarborough Hospital - Sunnybrook Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Oshawa (1) 1
West Park Healthcare Centre - Archives (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (55157) 55157
German (849) 849
French (674) 674
Russian (199) 199
Chinese (154) 154
Japanese (120) 120
Spanish (116) 116
Polish (112) 112
Hungarian (89) 89
Italian (57) 57
Korean (34) 34
Portuguese (26) 26
Dutch (21) 21
Turkish (20) 20
Romanian (17) 17
Bulgarian (15) 15
Czech (10) 10
Danish (7) 7
Finnish (7) 7
Lithuanian (7) 7
Hebrew (4) 4
Swedish (4) 4
Serbian (3) 3
Croatian (2) 2
Icelandic (2) 2
Slovak (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer, ISSN 0959-8049, 2010, Volume 46, Issue 13, pp. 2422 - 2431
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 72, Issue 3, pp. 695 - 701
Journal Article
Annals of Oncology, ISSN 0923-7534, 2015, Volume 26, Issue 8, pp. 1533 - 1546
The 14th St Gallen International Breast Cancer Conference (2015) reviewed substantial new evidence on locoregional and systemic therapies for early breast... 
Radiation therapy | Early breast cancer | St Gallen Consensus | Systemic adjuvant therapies | Surgery | early breast cancer | ADJUVANT CHEMOTHERAPY | ENDOCRINE THERAPY | PREMENOPAUSAL WOMEN | ESTROGEN-RECEPTOR | PATHOLOGICAL COMPLETE RESPONSE | TUMOR-INFILTRATING LYMPHOCYTES | OVARIAN-FUNCTION SUPPRESSION | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | radiation therapy | SENTINEL NODE | CONTRALATERAL PROPHYLACTIC MASTECTOMY | systemic adjuvant therapies | surgery | Carcinoma, Lobular - pathology | Receptors, Estrogen - metabolism | Humans | Carcinoma, Intraductal, Noninfiltrating - metabolism | Mastectomy - methods | Receptor, ErbB-2 - metabolism | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Anthracyclines - administration & dosage | Carcinoma, Lobular - therapy | Carcinoma, Intraductal, Noninfiltrating - therapy | Antineoplastic Agents, Hormonal - therapeutic use | Axilla | Carcinoma, Ductal, Breast - pathology | Female | Carcinoma, Ductal, Breast - metabolism | Mastectomy, Segmental - methods | Trastuzumab - administration & dosage | Carcinoma, Ductal, Breast - therapy | Taxoids - administration & dosage | Carcinoma, Intraductal, Noninfiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Radiotherapy, Adjuvant - methods | Carcinoma, Lobular - metabolism | Platinum Compounds - administration & dosage | Lymph Node Excision - methods | Neoplasm Staging | Practice Guidelines as Topic | Index Medicus | Special
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 163 - 171
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 08/2018, Volume 99, pp. 78 - 85
To investigate the outcome following adjuvant doxorubicin and ifosfamide in a prospective non-randomised study based on a soft tissue sarcoma (STS) patient... 
Growth pattern | Adjuvant treatment | Soft tissue sarcoma | Vascular invasion | Tumour size | Survival | Prognostic factors | Necrosis | METAANALYSIS | CANCER CENTERS | RANDOMIZED CLINICAL-TRIAL | DOXORUBICIN | FOLLOW-UP | IFOSFAMIDE | ONCOLOGY | Doxorubicin - therapeutic use | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Sarcoma - blood supply | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Incidence | Dose-Response Relationship, Drug | Neoplasm Recurrence, Local - pathology | Young Adult | Neoplasm Invasiveness - pathology | Adult | Female | Sarcoma - prevention & control | Soft Tissue Neoplasms - therapy | Ifosfamide - pharmacology | Ifosfamide - therapeutic use | Soft Tissue Neoplasms - mortality | Neoplasm Recurrence, Local - prevention & control | Risk Factors | Treatment Outcome | Soft Tissue Neoplasms - blood supply | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Radiotherapy, Adjuvant - methods | Soft Tissue Neoplasms - pathology | Survival Analysis | Aged | Neoplasm Recurrence, Local - epidemiology | Sarcoma - epidemiology | Doxorubicin - pharmacology | Medical research | Anthracyclines | Sarcoma | Medicine, Experimental | Radiotherapy | Risk factors | Cancer | Slopes | Risk groups | Toxicity | Ifosfamide | Radiation therapy | Risk analysis | Patients | Doxorubicin | Subgroups | Metastases | Confidence intervals | Tissue | Chemotherapy | Medical prognosis | Morphology | Risk assessment | Tumors | Index Medicus | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Soft tissue sarcoma; Adjuvant treatment; Prognostic factors; Vascular invasion; Growth pattern; Tumour size; Necrosis; Survival | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Journal Article